tirzepatide patent expiration date us When will the patents on MOUNJARO expire, and when will generic MOUNJARO be available? A Strategic Guide to Capitalizing

GLP-1 drugs have reshaped metabolic medicine, biopharma M&A hit its strongest quarter since 2020 earlier this year, and the FDA continues to approve new treatments at a steady pace despite leadership changes

A Primer on the Weight Loss, Health & Longevity Benefits of GLP-1 Receptor Agonists Reading Time: 7 minutes | GLP-1 (Glucagon-like peptide-1) receptor agonists (RAs) therapies are in demand for weight loss because of the obesity epidemic, and because they work

Within the first few days, some women notice a reduced appetite or mild digestive side effects, such as nausea, constipation, or diarrhea, while others may not see changes until after several doses

Factors such as nutrition, overall health, and how quickly the underlying trigger is addressed all play a role